May 14, 2019

In re HIV Antitrust Litigation

Track this case

Case overview

Case Number:

3:19-cv-02573

See also:

Court:

California Northern

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Edward M Chen

Firms

Companies

Government Agencies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. January 22, 2024

    HIV Drug Wholesalers' Attys Get $75M In Gilead Antitrust Case

    A California federal judge has given final approval to Gilead Sciences' $247 million settlement with direct purchasers of HIV medications, including an award of $75 million for attorney fees, ending claims the pharmaceutical giant worked with Teva Pharmaceuticals to delay generic versions.

49 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!